Say­ing good­bye to R&D chief, Flag­ship-backed Ax­cel­la drops PhII pro­gram as it fo­cus­es on long Covid, NASH

4 years ago
People
R&D

Man­u­fac­tur­ing roundup: Phar­maron se­cures ac­qui­si­tion of a Rhode Is­land fa­cil­i­ty; GSK to open hub in South Amer­i­ca

4 years ago
Manufacturing

Covid-19 roundup: NRx's med gets axed from NIH tri­al over fu­til­i­ty; A new drug for the pan­dem­ic en­ters the clin­ic

4 years ago
Coronavirus

For­mer Ed­i­tas CEO Ka­trine Bosley goes the VC route, join­ing ear­ly-stage in­vestor

4 years ago
People

LA biotech founder ar­rest­ed, charged in mur­der-for-hire scheme be­hind 2018 death

4 years ago
People

NI­H's new, in­de­pen­dent break­through drug ac­cel­er­a­tor ARPA-H gets its first em­ploy­ee

4 years ago
People

Flag­ship's lat­est biotech could turn some of the thou­sands of new pro­teins it dis­cov­ered in­to ther­a­pies — and it ...

4 years ago
Financing
Startups

This time around, Lyri­ca's in­ven­tor is de­vel­op­ing his North­west­ern dis­cov­er­ies at his own biotech

4 years ago
Startups

Eli Lil­ly set to in­vest $2.1B in home state man­u­fac­tur­ing boost

4 years ago
Pharma
Manufacturing

Up­dat­ed: US sees spike in Paxlovid us­age as Mer­ck­'s mol­nupi­ravir and As­traZeneca's Evusheld are slow­er off the shelf

4 years ago
Coronavirus

Almi­rall rolls out sales rep ar­ti­fi­cial in­tel­li­gence sys­tem, cut­ting pre-call prep and 'wind­shield time'

4 years ago
Pharma
Marketing

Pfiz­er and CD­MOs ramp up Paxlovid man­u­fac­tur­ing with Kala­ma­zoo plant ex­pan­sion lead­ing the way

4 years ago
Pharma
Manufacturing

Te­va, Al­ler­gan reach yet an­oth­er opi­oid set­tle­ment — ef­fec­tive­ly end­ing WV tri­al

4 years ago
Pharma
Law

Roche un­veils three new mon­key­pox tests as cas­es rise

4 years ago
Pharma
Diagnostics

New law­suit ac­cus­es GSK of 'de­vice hop­ping' to block gener­ic in­haler com­pe­ti­tion

4 years ago
Pharma
Law

FDA spells out the rules and re­stric­tions for states seek­ing to im­port drugs from Cana­da

4 years ago
Pharma
FDA+

Chica­go-area biotech sends 2nd drug to In­di­a's reg­u­la­tors; Pen­ny stock play­er spins out PhI­II can­cer can­di­date in­to ...

4 years ago
News Briefing

While down 87% YOY, Evelo gets Flag­ship and oth­ers to in­fuse new cap­i­tal for come­back hope

4 years ago
Financing

Tak­ing an­oth­er shot at mR­NA glo­ry, Cure­Vac inks on­col­o­gy pact while keep­ing up with Covid work

4 years ago
Deals

Bavar­i­an Nordic nets ma­jor vac­cine con­tract to re­spond to mon­key­pox out­break

4 years ago
Pharma
Manufacturing

An­tios' HBV col­lab axed af­ter clin­i­cal hold, but biotech be­lieves safe­ty in­ci­dent is not treat­ment-re­lat­ed

4 years ago
Deals
FDA+

For­mer Prin­cip­ia team looks to shake up co­va­lent small mol­e­cules again, this time at 'earthquake' scale

4 years ago
Financing
Startups

Life sci­ences de­vel­op­er Bio­Med Re­al­ty buys San Fran­cis­co ho­tel for $75M — re­port

4 years ago
Deals

All about ac­cess: Pfiz­er moves to a non-prof­it mod­el for drug sales in 45 low­er-in­come coun­tries

4 years ago
Pharma
First page Previous page 524525526527528529530 Next page Last page
A service from the Financial Times